keyword
enzymat
assay
hepat
viru
rhinoviru
proteas
picornaviru
screen
isatin
structurebas
drug
design
correspond
banerje
develop
novel
antivir
requir
knowledg
viral
life
cycl
molecular
detail
daunt
task
involv
extens
invest
frequent
result
failur
exist
signific
common
among
viru
famili
manner
host
interact
identifi
target
common
rather
specif
featur
may
lead
develop
broadli
use
antivir
target
proteas
hepat
viru
hav
fecoor
transmit
viru
famili
picornavirida
identif
potenti
antivir
proteas
viabl
drug
target
requir
hav
well
picornavirus
posttransl
proteolysi
viral
polyprotein
inhibit
host
innat
immun
pathway
comput
screen
follow
chemic
synthesi
experiment
valid
result
identif
compound
low
micromolar
concentr
could
inhibit
hav
activ
compound
test
experiment
proteas
human
rhinoviru
anoth
member
picornavirida
famili
compar
result
comput
studi
proteas
member
picornaviru
famili
indic
compound
identifi
could
potenti
gener
inhibitor
picornaviru
proteas
acut
hepat
caus
hav
infect
typic
selflimit
howev
recent
larg
outbreak
sever
part
world
preval
vaccineresist
strain
propens
viru
caus
liver
failur
contract
later
stage
life
coupl
lack
specif
treatment
support
care
underscor
need
develop
effect
antivir
combat
occurr
hav
infect
hav
small
nonenvelop
icosahedr
rna
viru
belong
hepatoviru
genu
picornavirida
famili
positivestrand
rna
genom
hav
serv
templat
translat
replic
translat
polyprotein
autocleav
viral
proteas
structur
nonstructur
protein
fig
includ
viral
polymeras
crucial
initi
replic
proteas
preferenti
cleav
glutamin
fig
also
cleav
sever
cellular
protein
fig
arrest
translat
promot
viral
replic
subvert
host
innat
immun
pathway
member
picornavirida
famili
util
similar
proteolyt
mechan
gener
viral
protein
cleav
cellular
compon
establish
infect
similarli
sarscov
coronavirida
famili
employ
proteas
autoprocess
viral
protein
proteas
constitut
vital
drug
target
therapeut
intervent
comput
bioinformat
approach
provid
essenti
insight
drugprotein
interact
molecular
level
util
effect
speed
design
develop
improv
antivir
key
protein
computeraid
drug
discoveri
cadd
special
disciplin
structurebasedligandbas
drug
design
boast
multipl
success
stori
area
antivir
among
other
develop
fdaapprov
drug
zanamivir
oseltamivir
influenza
viru
saquinavir
hiv
valid
efficaci
techniqu
among
mani
peptidomimet
smallmolecul
inhibitor
test
viral
protein
isatin
deriv
constitut
interest
class
versatil
lead
compound
isatin
shown
antivir
activ
broad
spectrum
virus
sarscov
hepat
c
viru
hiv
addit
antitumor
antibacteri
antiangiogen
biolog
activ
studi
employ
combin
strategi
virtual
screen
comput
drug
design
follow
chemic
synthesi
compound
favor
bind
free
energi
experiment
valid
vitro
experi
cadd
structurebas
approach
util
effect
screen
smallmolecul
inhibitor
proteas
hav
crucial
effector
life
cycl
viru
also
attempt
modifi
isatin
compound
gener
potenti
lead
compound
hav
proteas
best
knowledg
first
descript
isatin
deriv
effect
inhibitor
hav
proteas
extend
comput
analys
compound
proteas
member
picornaviru
famili
indic
compound
act
plausibl
broadrang
inhibitor
picornavir
proteas
identif
compound
hav
structurebas
virtual
screen
crystal
structur
hav
proteas
pdb
id
util
screen
dock
identifi
potenti
inhibitor
catalyt
site
proteas
triad
form
tabl
molecular
structur
formula
compound
identifi
molecular
weight
dalton
correspond
inhibit
constant
k
lm
obtain
experiment
hav
proteas
fig
bind
pocket
encompass
catalyt
site
oxyanion
hole
along
nearbi
residu
involv
substrat
bind
identifi
potenti
activ
site
activ
site
predict
program
aad
one
million
organ
molecul
zinc
databas
screen
bind
pocket
hav
proteas
use
rapid
screen
protocol
raspd
order
select
best
hit
compound
subject
atom
level
dock
score
use
pardock
number
molecul
highest
predict
bind
energi
subject
short
molecular
dynam
simul
eventu
seven
compound
tabl
show
potenti
form
strong
interact
proteas
subject
ns
simul
order
understand
dynam
bind
enzym
addit
virtual
screen
approach
also
consid
indol
possibl
inhibitori
compound
hav
proteas
indol
recent
past
turn
effect
scaffold
biolog
medicin
also
materi
scienc
indol
backbon
variou
substitu
core
structur
abil
display
spectrum
function
particular
due
broad
structur
divers
isatin
shown
affect
wide
rang
biolog
target
comput
screen
varieti
isatin
deriv
hav
proteas
found
two
modif
protect
group
isatin
compound
tabl
result
better
interact
target
reflect
dock
studi
well
ns
molecular
dynam
simul
compound
contain
triphenylmethyl
protect
group
restrict
conform
compound
bind
pocket
proteas
thu
facilit
snug
fit
compound
substrat
mimic
nacetyl
protect
group
contain
amid
bond
competit
inhibit
attack
nucleophil
substrat
amid
bond
hinder
transfer
proton
sc
ne
necessari
substrat
cleavag
combin
approach
virtual
screen
isatinbas
drug
design
result
identif
nine
biggest
cluster
inform
obtain
use
ligand
rmsd
plot
one
frame
ligand
found
stabl
time
molecular
dynam
simul
select
plot
proteinligand
interact
diagram
overlap
pose
show
hydrophob
hydrogen
bond
contact
activ
site
residu
hav
proteas
dock
versu
postdock
stabl
conform
red
circl
show
common
interact
residu
dock
biggest
cluster
frame
bcf
respect
proteinligand
complex
blue
color
denot
hydrophob
residu
initi
dock
pose
red
color
residu
label
black
denot
hydrophob
residu
bcf
green
color
residu
hydrogen
bond
residu
blue
line
green
line
show
hydrogen
bond
dock
pose
bcf
respect
residu
found
conserv
maximum
number
time
ns
molecular
dynam
simul
plot
gener
use
ligplot
softwar
b
interact
potent
inhibitor
compound
catalyt
site
hav
proteas
potenti
efficaci
compound
iupac
name
tabl
interact
diagram
fig
simul
data
fig
tabl
support
possibl
strong
bind
compound
hav
proteas
ligand
protein
backbon
rmsd
plot
fig
propos
nine
compound
remain
stabl
ns
molecular
dynam
simul
except
compound
compound
found
drift
anoth
site
compris
similar
residu
origin
target
site
also
ligand
rmsd
compound
show
fluctuat
approxim
ns
initi
ns
simul
howev
extens
simul
upto
ns
show
compound
eventu
get
stabil
conform
similar
initi
dock
pose
fig
fig
could
potenti
reflect
actual
bind
mechan
conduct
experiment
studi
compound
identifi
silico
bind
studi
purchas
compound
isatin
compound
synthes
inhous
fig
kinet
cytotox
analysi
compound
hav
proteas
viral
strain
recombinantli
express
e
coli
rosetta
plyss
cell
purifi
sequenti
ninta
sizeexclus
chromatographi
fig
mutat
version
proteas
catalyt
site
cystein
nonessenti
surfac
cystein
modif
gener
use
sitedirect
mutagenesi
protein
purifi
ident
condit
util
wildtyp
enzymat
inhibit
assay
peptid
edansglrtq
sfsdabcyl
contain
cleavag
site
mark
star
flank
fluorophor
quencher
nand
ctermin
end
respect
util
mutat
contain
modif
previous
shown
inhibit
activ
serv
neg
control
assay
hav
cleav
peptid
immedi
shown
fig
wherea
mutat
show
appreci
cleavag
activ
even
min
incub
satur
bind
experi
carri
determin
dissoci
constant
k
nine
compound
tabl
substrat
cleavag
follow
michaelismenten
model
tabl
kinet
paramet
develop
effect
compound
activ
could
examin
initi
veloc
condit
tabl
inhibit
constant
k
tabl
calcul
leastsquar
fit
use
graphpad
prism
la
jolla
ca
usa
sinc
fluoresc
respons
mask
compound
inner
filter
effect
correct
requir
compound
test
cytotox
standard
mtt
assay
found
nontox
fairli
high
concentr
micromolar
rang
tabl
tabl
data
predict
bind
free
energi
compound
hav
proteas
use
pardock
autodock
swissdock
mmbappl
mmgbsa
mmpbsa
along
experiment
obtain
k
valu
mmbappl
mmgbsa
mmpbsa
score
obtain
ns
molecular
dynam
simul
run
three
dock
softwar
show
correl
wrt
k
valu
howev
averag
proteinligand
score
stabl
part
complex
ns
simul
use
bind
free
energi
score
algorithm
mmbappl
show
strong
correl
wrt
k
valu
bappl
score
algorithm
util
pardock
calcul
bind
free
energi
proteinligand
complex
calcul
snapshot
proteinligand
complex
molecular
dynam
simul
known
mmbappl
score
calcul
energi
obtain
snapshot
simul
provid
averag
bind
free
energi
complex
success
methodolog
reli
screen
bind
free
energi
threshold
well
overal
bind
affin
calcul
period
stabl
molecular
dynam
simul
use
mmbappl
calcul
correl
compound
data
consid
due
drift
catalyt
site
proteas
inhibit
data
compound
obtain
fluorimetr
enzymat
assay
fit
better
alloster
sigmoid
model
rather
equat
competit
inhibit
high
k
ae
lm
indic
compound
probabl
bind
offsit
predict
bind
pocket
hav
proteas
find
plausibl
reason
anomali
expect
versu
actual
bind
carri
detail
comput
bind
mode
analysi
compound
compar
compound
analysi
show
distanc
one
residu
catalyt
triad
central
atom
compound
increas
respect
time
simul
fig
although
compound
stay
near
catalyt
triad
similar
hydrophob
hydrogen
bond
interact
throughout
durat
simul
fig
interact
diagram
fig
show
hav
residu
eventu
interact
compound
significantli
differ
initi
dock
posit
suggest
possibl
shift
bind
site
compound
appear
form
strong
interact
residu
present
away
catalyt
site
confirm
drift
compound
initi
dock
pose
target
bind
site
offsit
share
six
residu
target
site
fig
partial
explain
anomal
bind
pose
mtt
assay
show
compound
caus
cell
death
lm
concentr
given
compound
show
propens
possibl
drift
catalyt
substratebind
site
high
inhibit
constant
potenti
toxic
twice
inhibitori
concentr
compound
use
studi
vitro
enzymat
assay
demonstr
compound
except
compound
exhibit
competit
inhibit
low
micromolar
rang
tabl
best
k
valu
lm
demonstr
compound
respect
compound
also
show
effect
inhibit
k
valu
lm
respect
compound
highest
k
ae
lm
among
eight
compound
howev
choos
viabl
lead
compound
also
consid
cytotox
display
compound
standard
mtt
assay
although
found
eight
compound
fairli
benign
cell
cultur
cytotox
display
least
cell
remain
viabl
even
treat
lm
compound
time
inhibitori
concentr
compound
although
display
better
k
valu
case
found
caus
higher
cytotox
cell
viabil
respect
lm
inhibitor
concentr
five
distinct
molecular
dynam
simul
ns
run
best
lead
compound
mmgbsa
mmpbsa
mmbappl
score
along
standard
mean
error
calcul
enhanc
confid
protocol
tabl
analysi
inhibitori
potenti
cellular
cytotox
clearli
indic
zinc
compound
isatinbas
compound
best
lead
compound
lowest
k
valu
low
micromolar
rang
mtt
assay
show
viabl
cell
inhibitor
concentr
high
lm
detail
analysi
ns
molecular
dynam
simul
reveal
compound
averag
made
four
hydrogen
bond
activ
site
residu
hav
proteas
throughout
simul
fig
favor
structur
obtain
ns
molecular
dynam
simul
show
hydrogen
bond
substratebind
residu
consist
backbon
nh
atom
backbon
sidechain
nh
atom
along
multipl
hydrophob
contact
result
high
bind
affin
residu
gli
gli
locat
site
proteas
respect
fig
isatinbas
compound
show
network
multipl
hydrogen
bond
hydrophob
interact
substratebind
catalyt
site
residu
favor
structur
obtain
overal
trajectori
show
compound
form
hydrogen
bond
sh
nh
among
interact
tabl
satur
bind
experi
hav
proteas
compound
dissoci
constant
k
valu
mention
along
confid
interv
ci
graph
plot
compound
concentr
lm
versu
percentag
enzym
bound
state
case
r
squar
valu
curvefit
carri
use
graphpad
prism
curvefit
onesit
specif
bind
increas
distanc
thiol
group
imidazol
group
catalyt
site
observ
eight
compound
probabl
crucial
inhibit
proteas
activ
assay
inhibit
hrv
compound
compar
seen
hav
structur
function
similar
among
proteas
picornavirus
fig
encourag
us
explor
effect
compound
proteas
human
rhinoviru
fig
comput
dock
fig
simul
studi
along
experiment
assay
tabl
carri
describ
indic
inhibitori
effect
compound
proteas
human
rhinoviru
compar
demonstr
hav
shown
tabl
case
also
compound
display
inhibit
low
micromolar
rang
k
valu
lm
respect
structurebas
drug
design
becom
preval
method
obtain
ration
design
inhibitor
specif
diseaseassoci
protein
virtual
screen
perform
exist
databas
small
peptid
nonpeptid
molecul
yield
valuabl
hit
upon
optim
modif
display
better
interact
target
protein
verifi
molecular
dock
simul
studi
molecul
show
advantag
interact
paramet
subject
vitro
test
follow
cycl
modif
experiment
valid
acut
hepat
caus
hepat
viru
although
primarili
nonfat
creat
signific
morbid
world
popul
sporad
outbreak
around
world
absenc
specif
treatment
increas
healthcar
burden
associ
viral
infect
import
proteas
process
viral
protein
make
key
compon
establish
infect
structur
function
similar
among
proteas
picornavirus
make
enzym
viabl
drug
target
gener
drug
develop
current
studi
util
principl
structurebas
drug
design
identifi
novel
compound
proteas
hav
sever
compound
shown
efficaci
function
hav
proteas
low
micromolar
rang
along
reduc
cytotox
comput
analys
select
nine
compound
seven
zinc
librari
two
isatin
deriv
inhibitori
activ
compound
valid
vitro
enzymat
assay
found
eight
nine
compound
bound
competit
hav
show
inhibit
low
micromolar
rang
compound
propos
best
lead
base
effect
inhibit
low
cytotox
compound
also
test
proteas
anoth
member
picornaviru
famili
compar
inhibit
paramet
obtain
among
previous
report
peptidebas
inhibitor
hav
proteas
dncbzserin
blacton
show
competit
inhibit
lm
howev
enantiom
irrevers
inactiv
much
lower
inhibitori
potenti
activ
ketoglutamin
analog
demonstr
k
lm
nonpeptid
inhibitor
hav
display
inhibit
nanomolar
rang
probabl
occas
due
except
low
k
valu
halopyridinyl
ester
substrat
peptidyl
monofluoromethyl
keton
inhibitor
hav
ineffect
due
poor
oral
bioavail
peptid
aldehyd
inhibitor
show
potent
activ
tabl
determin
inhibit
constant
k
compound
hav
proteas
calcul
k
valu
mention
along
confid
interv
ci
graph
plot
peptid
concentr
lm
versu
reaction
veloc
fluoresc
unit
fu
case
r
squar
valu
curvefit
carri
use
graphpad
prism
without
compound
compound
hav
howev
similarli
effect
picornavir
proteas
show
less
inhibit
proteas
hand
tripeptid
aldehyd
inhibitor
show
low
micromolar
rang
inhibitori
activ
isatin
inhibitor
show
strong
activ
toxic
cell
cultur
even
nanomolar
concentr
isatinbas
compound
design
us
compound
shown
potent
inhibit
also
essenti
nontox
even
high
inhibitor
concentr
lm
isatin
deriv
shown
inhibit
sarscoronaviru
proteas
compar
activ
far
know
first
descript
isatin
effect
inhibitor
hav
proteas
found
mmbappl
score
protocol
calcul
bind
affin
proteinligand
complex
variou
bind
pose
occur
molecular
simul
score
strongli
correl
experiment
k
valu
compar
mmgbsa
mmpbsa
score
increas
confid
protocol
fig
moreov
stringent
screen
cutoff
dock
bind
energi
threshold
like
play
key
role
predict
true
potenti
inhibitor
fig
tabl
cell
growth
inhibit
compound
use
mtt
assay
cell
expos
compound
continu
h
increas
concentr
lm
follow
mtt
assay
data
calcul
percentag
cell
viabil
respect
compound
concentr
lm
experi
perform
triplic
data
present
mean
ae
sd
later
show
low
micromolar
rang
inhibit
via
experiment
enzym
bind
assay
thu
base
comput
function
studi
conclud
compound
abl
show
strong
inhibitori
potenti
low
micromolar
concentr
proteas
two
member
picornavirida
famili
hav
hrv
picornavirida
famili
consist
speci
group
genera
activ
site
proteas
famili
experiment
determin
structur
show
common
amino
acid
pattern
consist
eight
polar
residu
name
thr
glu
tyr
cy
gln
asp
nonpolar
residu
name
leu
val
phe
gli
ile
depict
approxim
bind
pocket
similar
although
signific
differ
overal
proteas
structur
tabl
common
residu
give
rise
hydrophob
contact
hydrogen
bond
interact
hydrogen
bond
donor
hydrogen
bond
acceptor
ideal
ligand
guid
observ
extend
comput
analysi
nine
compound
activ
site
proteas
import
member
picornaviru
famili
polioviru
coxsackieviru
foot
mouth
diseas
viru
enterovirus
well
fig
tabl
activ
site
residu
proteas
picornavirus
display
potenti
form
averag
hydrogen
bond
along
hydrophob
contact
compound
studi
indic
compound
show
accept
adm
properti
tabl
bind
profil
tabl
serv
effect
inhibitor
proteas
well
conclus
degre
intraspeci
overlap
activ
site
picornaviru
proteas
comput
experiment
studi
indic
efficaci
identifi
compound
broadrang
inhibitor
seven
proteas
compound
isatin
deriv
particular
could
possibl
use
lead
compound
test
famili
proteas
work
thu
highlight
feasibl
design
develop
gener
drug
proteas
picornaviru
famili
schemat
represent
methodolog
adopt
identifi
design
potenti
inhibitor
hav
proteas
shown
fig
xray
crystal
structur
hav
proteas
pdb
id
obtain
rcsb
accord
publish
literatur
catalyt
mechan
hav
involv
abstract
proton
sc
ne
result
thiolat
ion
nucleophil
attack
carbonyl
carbon
peptid
substrat
comput
studi
ioniz
state
kept
ne
interact
sc
h
via
hydrogen
bond
histidin
kept
hie
state
use
forc
field
probabl
bind
pocketssit
predict
use
activ
site
predict
program
aad
predict
bind
pocket
vicin
catalyt
triad
select
analysi
protein
atom
assign
partial
atom
charg
van
der
waal
bond
paramet
use
amber
forc
field
antechamb
modul
amber
use
assign
paramet
charg
ligand
atom
use
gaff
respect
million
molecul
zinc
databas
screen
catalyt
site
hav
proteas
filter
best
hit
individu
dock
score
proteas
screen
protocol
raspd
test
valid
dud
dataset
earlier
show
best
earli
enrich
approxim
activ
molecul
retriev
first
dataset
dock
score
studi
carri
use
pardock
threshold
least
bind
energi
util
cutoff
compound
select
threshold
criterion
valid
via
test
dock
algorithm
variou
enzym
target
respect
decoy
avail
dud
site
pardock
dock
protocol
abl
decoy
threshold
hydrogen
bond
distanc
calcul
heavi
atom
within
accept
limit
cutoff
donoracceptor
heavi
atom
distanc
cut
degre
bond
angl
set
tabl
fig
compound
show
significantli
high
bind
subject
short
molecular
dynam
simul
molecular
dynam
simul
carri
use
amber
suit
account
flexibl
ligand
activ
site
residu
explicit
solvent
salt
effect
requir
number
na
cl
ion
ad
system
follow
solvat
thick
layer
water
model
around
proteinligand
complex
prepar
system
first
subject
minim
solvent
molecul
alon
steepest
descent
conjug
gradient
step
follow
minim
whole
solutesolv
system
steepest
descent
conjug
gradient
step
energi
minim
system
heat
gradual
nvt
ensembl
k
subject
proteinligand
complex
harmon
restraint
afterward
system
equilibr
npt
ensembl
k
pressur
bar
use
berendsen
barostat
releas
harmon
restraint
complex
six
step
ps
final
restraint
releas
ns
product
run
npt
ensembl
p
bar
k
carri
overal
bind
free
energi
proteinligand
complex
throughout
trajectori
calcul
use
mmbappl
mmgbsa
mmpbsa
mmgbsa
mmpbsa
popular
approach
molecular
mechan
energi
combin
poissonboltzmann
gener
born
surfac
area
continuum
solvat
get
estim
bind
free
energi
small
ligand
biolog
macromolecul
mmbappl
empir
score
function
predict
bind
free
energi
proteinligand
complex
score
gener
snapshot
molecular
dynam
simul
provid
better
understand
inhibitori
potenti
compound
time
base
predict
bind
free
energi
system
simul
root
mean
squar
deviat
energi
kinet
potenti
total
densiti
temperatur
monitor
ensur
standard
deviat
valu
within
accept
limit
total
short
molecular
dynam
simul
ns
perform
major
compound
studi
show
instabl
proteinligand
complex
reflect
rmsd
valu
complex
show
stabl
behavior
ns
simul
subject
analysi
extend
simul
run
till
ns
understand
behavior
ligand
dock
complex
bind
energi
complex
calcul
use
mmbappl
part
molecular
dynam
simul
complex
found
exist
maximum
time
fig
compound
isatin
inhous
librari
dock
score
hav
proteas
check
inhibitori
potenti
isatin
compound
show
low
bind
potenti
comput
henc
iter
modif
structur
undertaken
eventu
modifi
isatin
compound
show
better
result
term
interact
bind
free
energi
hav
purchas
sigmaaldrich
bangalor
india
use
without
purif
nprotect
isatin
compound
compound
prepar
accord
procedur
outlin
literatur
fig
tabl
determin
inhibit
constant
k
compound
proteas
calcul
k
valu
mention
along
confid
interv
ci
graph
plot
peptid
concentr
lm
versu
reaction
veloc
fluoresc
unit
fu
case
r
squar
valu
curvefit
carri
use
graphpad
prism
type
inhibit
flowchart
explain
methodolog
employ
screen
design
synthesi
vitro
valid
inhibitor
hav
proteas
protocol
start
obtain
coordin
inform
crystal
structur
follow
activ
sitebas
ligand
screen
dock
molecular
dynam
simul
studi
lead
seven
propos
molecul
zinc
databas
simultan
iter
modif
isatinbas
scaffold
lead
identif
two
best
binder
synthes
propos
molecul
test
hav
via
enzym
assay
data
obtain
experi
analyz
use
graphpad
prism
version
window
graphpad
softwar
wwwgraphpadcom
determin
competit
inhibit
data
check
curvefit
equat
v
max
k
ik
substrat
concentr
enzym
veloc
v
max
maximum
enzym
veloc
k
michaelismenten
constant
inhibitor
concentr
k
inhibit
constant
data
fit
alloster
sigmoid
model
equat
use
v
max
h
k
prime
h
h
hill
slope
k
prime
relat
micha
constant
analysi
use
mode
inhibit
noncompetit
mix
inhibit
result
higher
regress
coeffici
standard
error
wider
confid
interv
indic
select
equat
curvefit
justifi
cell
maintain
dulbecco
modifi
eagl
medium
gibco
thermo
scientif
waltham
usa
supplement
fetal
bovin
serum
gibco
thermo
scientif
environ
co
humid
toxic
studi
cell
seed
plate
corn
merck
seed
densiti
cell
per
well
upon
reach
confluenc
cell
treat
increas
concentr
compound
incub
h
subsequ
mtt
assay
carri
amount
mm
mtt
invitrogen
thermo
scientif
stock
solut
ad
well
incub
h
media
remov
dmso
ad
mix
thoroughli
follow
incub
min
read
taken
nm
use
micropl
spectrophotomet
system
thermo
scientif
assay
done
triplic
result
express
percentag
cell
viabil
theoret
studi
reveal
pattern
activ
site
residu
similar
proteas
wellknown
member
picornavirida
famili
potenti
inhibitor
identifi
hav
comput
analyz
proteas
pdb
id
use
protocol
similar
comput
studi
perform
six
member
polioviru
coxsackieviru
foot
mouth
diseas
viru
enterovirus
picornaviru
famili
addit
support
inform
may
found
onlin
support
inform
section
end
articl
fig
converg
plot
rmsd
ligand
backbon
hav
proteas
bound
compound
fig
synthesi
data
h
c
spectra
compound
fig
sizeexclus
chromatogram
purifi
hav
proteas
doubl
mutant
fig
roc
curv
four
case
ach
ampc
hivpr
target
enzym
tabl
mmgbsa
mmpbsa
mmbappl
estim
bind
free
energi
along
standard
error
mean
five
separ
molecular
dynam
simul
ns
best
inhibitor
compound
hav
proteas
tabl
activ
site
residu
similar
score
proteas
speci
picornavirida
famili
tabl
predict
bind
free
energi
compound
proteas
differ
picornavirus
obtain
dock
score
tabl
comput
predict
adm
properti
identifi
compound
tabl
case
studi
target
enzym
check
dud
decoy
dataset
